We report the case of a 30‐year‐old woman diagnosed with BRAF V600E–mutant pulmonary Langerhans cell histiocytosis who was treated with dabrafenib in combination with trametinib. This evidence concerns the gene BRAF and Langerhans cell histiocytosis.